Bemotrizinol gains FDA approval

On 9 June 2026, the US FDA approved this UV active for use in sunscreen formulations at a maximum permitted level of 6% w/w. READ MORE.

ASCC Position Statement – ‘Reef Safe’

ASCC POSITION STATEMENT – “REEF SAFE” Prepared by John Staton - ASCC Technical Committee August 2019 – Updated August 2022

Fragrance Regulation Changes

European Commission & IFRA Updates

Regulatory Toxicology and Pharmacology

The difference between hazard and risk. Ensuring the safety of fragrances is a priority for both consumers and industry.

A note from the ASCC Technical Committee

Bemotrizinol (Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine, or BEMT, CAS No. 187393-00-6) is a broad spectrum sunscreen active with absorbance in the UVA (343nm) and UVB (310nm) regions.

On 9 June 2026, the US FDA approved this UV active for use in sunscreen formulations at a maximum permitted level of 6% w/w. It is also recognised by the FDA as GRASE (Generally Regarded as Safe and Effective.) It is the first UV active to be approved by the FDA since 1999.

Formulators and marketers may now include this material in sunscreen products intended to be marketed in the USA.

It is currently approved in Australia at 10% w/w.

Bemotrizinol gains FDA approval

Bemotrizinol gains FDA approval

Table of Contents

ASCC Position Statement – ‘Reef Safe’

Fragrance Regulation Changes

Regulatory Toxicology and Pharmacology

A note from the ASCC Technical Committee

Useful Links